Aspira Pathlab & Diagnostics Ltd.

BSE: 540788

₹96.99

up-down-arrow3.99 (4.29%)

As on 04-Sep-2026 11:22IST

Market cap

info icon

₹96 Cr

Revenue (TTM)

info icon

₹26 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

7.9

Div. Yield

info icon

0 %

Aspira Pathlab Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 93.00 High: 96.99

52 Week Range

Low: 49.00 High: 135.88

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹0 Cr

  • ROEROE information

    18.1 %

  • ROCEROCE information

    19.3 %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    62.9

  • Debt to EquityDebt to Equity information

    0.1

  • Book ValueBook Value information

    ₹11.8

  • EPSEPS information

    ₹-0.4

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    10,293,000

10 Years Aggregate

CFO

₹-1.15 Cr

EBITDA

₹2.00 Cr

Net Profit

₹-12.60 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Aspira Pathlab
46.6 -16.2 -22.7 51.9 33.9 9.5 --
BSE Healthcare
17.7 0.7 9.9 15.5 22.6 13.8 12.2
As on 04-Sep-2026
Company
2025
2024
2023
2022
2021
Aspira Pathlab
9.0 52.6 -9.0 -44.2 180.6
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Aspira Pathlab
97.0 95.7 25.9 -0.5 -2.3 -3.4 -- 7.9
7.6 6.6 4.5 0.4 -- 4.3 104.7 0.5
1,881.4 31,555.6 2,890.8 546.3 23.0 23 58.2 12.1
1,474.5 38,562.9 4,683.4 552.3 15.6 14.9 69.3 9.4
12.2 12.4 0.0 -1.7 -- -7.2 -- 0.5
766.8 32,120.0 4,212.5 190.8 11.9 9.4 157.2 8.5
109.9 230.1 57.3 0.2 0.5 0.3 1534.1 3.8
NG
115.0 38.5 16.9 1.9 7.8 5.3 20 1.1
12.7 29.5 0.0 -8.7 -48,627.8 -60 -- 2.6
69.4 29.6 23.5 -3.6 -9.3 -- -- -11.3

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Aspira Pathlab

Hospital activities

  • Incorporated

    1973

  • Chairman

    Haseeb A Drabu

  • Managing Director

    --

  • Headquarters

    Mumbai, Maharashtra

  • Website

    www.aspiradiagnostics.com

FAQs for Aspira Pathlab

The share price of Aspira Pathlab & Diagnostics Ltd is ₹96.99 (BSE) as of 04-Sep-2026 11:22 IST. Aspira Pathlab & Diagnostics Ltd has given a return of 33.92% in the last 3 years.

Since, TTM earnings of Aspira Pathlab & Diagnostics Ltd is negative, P/E ratio is not available.
The P/B ratio of Aspira Pathlab & Diagnostics Ltd is 7.85 times as on 03-Sep-2026, a 219 premium to its peers’ median range of 2.46 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
43.37
7.21
2024
0.00
3.15
2023
0.00
2.25
2022
14.96
5.22
2021
21.24
3.53

The 52-week high and low of Aspira Pathlab & Diagnostics Ltd are Rs 135.88 and Rs 49.00 as of 04-Sep-2026.

Aspira Pathlab & Diagnostics Ltd has a market capitalisation of ₹ 96 Cr as on 03-Sep-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Aspira Pathlab & Diagnostics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...